Showing 401 - 420 results of 1,769 for search '(( 1 (teer OR per) decrease ) OR ( 10 ((we decrease) OR (((a decrease) OR (mean decrease)))) ))*', query time: 0.28s Refine Results
  1. 401
  2. 402
  3. 403
  4. 404

    A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries by Mason, Helen

    Published 2014
    “…Cumulative population health effects were quantified as life years gained (LYG) over a 10 year time frame. The costs of each policy were estimated using evidence from comparable policies and expert opinion including public sector costs and costs to the food industry. …”
    Get full text
    Get full text
  5. 405
  6. 406
  7. 407
  8. 408

    Amlexanox-loaded nanoliposomes showing enhanced anti-inflammatory activity in cultured macrophages: A potential formulation for treatment of oral aphthous stomatitis by Abouzid, Afaf

    Published 2023
    “…Notably, %TNF-α dramatically decreased to 57 ± 4.05% of control, for cells treated with drug-free liposomes (500 μg/mL total lipid) indicating the anti-inflammatory activity of SPC lipid component per se, which led to synergistic effect as evident from the augmentation of AMX anti-inflammatory activity in D-L1 formulation. …”
    Get full text
    Get full text
  9. 409
  10. 410
  11. 411
  12. 412

    Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 by Sirota, Sarah Brooke

    Published 2024
    “…From 2019 to 2021, the global all-age incidence rate fell by 0·5% (–0·8 to –0·1). Globally, the incidence rate of URIs was 162 484·8 per 100 000 population (144 834·0 to 183 289·4) in 2021, a decrease of 10·5% (–12·4 to –8·4) from 1990, when the incidence rate was 181 552·5 per 100 000 population (160 827·4 to 206 214·7). …”
    Get full text
    Get full text
    Get full text
    article
  13. 413
  14. 414
  15. 415
  16. 416
  17. 417

    Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: A cross-sectional study in the State of Qatar by El Hajj, Maguy Saffouh

    Published 2016
    “…The study objectives were to assess Qatar pharmacists' involvement in CVD health promotion, to identify the activities that they currently provide to patients with CVD risk factors, to describe their attitudes towards their involvement in CVD prevention and to assess their perceived barriers for provision of CVD prevention services Method We conducted a cross-sectional survey of community and ambulatory pharmacists in Qatar. …”
    Get full text
    Get full text
  18. 418
  19. 419
  20. 420